Desk Score
Mint Med
Mint Med is a national, no-membership compounded-GLP-1 telehealth platform offering semaglutide and tirzepatide on a flat "all doses" price — avoiding the per-tier escalation common as patients titrate up.
- Semaglutide
- $159/mo
- Tirzepatide
- $159/mo
- Coverage
- 36 states
- Brand-name
- Compounded only
Weigh Mint Med against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Mint Med vs CoreAge Rx. Because Mint Med dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
What the Desk likes
- $159 flat 'all doses' pricing — no per-tier escalation as you titrate up, unlike competitors that start cheap then jump past $200
- No membership — pay-as-you-go monthly, cancel anytime with 48-hour notice
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- 36 states listed explicitly — strong coverage
Where points come off
- Easily confused with Mint Medical Clinic (a separate Utah-only med spa)
- 503A/503B pharmacy partner not named, and the compounding designation isn't specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law, arbitration venue, and physical address not disclosed
The Desk's briefing — C+
Best for: Readers who want flat $159 all-doses compounded GLP-1 with no membership.
Mint Med ranks #65 of 498 providers scored — see #1, CoreAge Rx on the board.
Related dispatches
- #64Maves79/100 · C+
- #66Navio MD79/100 · C+
- #67Rebody Health79/100 · C+
- #68Bodybuilding Health+76/100 · C
- #69Care Bare Rx76/100 · C
- #70Optimized Health78/100 · C+
Everyone else on the board (19)
Pricing and verification reflect Mint Med's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Mint Med's site. Not medical advice; see our disclosure.